Skip to search.
 FTSE 100 Down 1.50%

Amicus Therapeutics, Inc. (FOLD)

-NasdaqGM
14.01 Up 0.38(2.75%) 17:50 - Nasdaq Real Time Price
Add to Portfolio
Prev Close:13.63
Open:13.82
Bid:13.98 x 100
Ask:13.99 x 400
1y Target Est:16.50
Beta:2.42
Earnings Date:5 Aug - 10 Aug (Est.)
Day's Range:13.76 - 14.17
52wk Range:3.50 - 14.65
Volume:1,471,538
Avg Vol (3m):1,862,940
Market Cap:1.62b
P/E (ttm):N/A
EPS (ttm):-0.94
Div & Yield:N/A (N/A)
Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
FOLDUp 2.75%1.62b
SHPGDown 0.73%47.02b

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):1,711.22
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-1.05
Quarterly EPS Est (Jun-15) :-0.24
Mean Recommendation*:1.6
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Amicus Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines for various rare and orphan diseases. more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback